Neurocrine Biosciences (NBIX) Goodwill & Intangibles (2022 - 2025)

Neurocrine Biosciences' Goodwill & Intangibles history runs 4 years deep, the most recent figure standing at $35.7 million for Q3 2025.

• Quarterly Goodwill & Intangibles fell 12.07% year-over-year to $35.7 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $35.7 million (down 12.07% YoY) and the FY2024 annual result came in at $42.2 million, up 2.18% from the prior year.
• Goodwill & Intangibles was $35.7 million for Q3 2025 at Neurocrine Biosciences, down from $37.2 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $42.8 million in Q1 2023 and bottomed at $35.7 million in Q3 2025.
• A 4-year average of $40.1 million and a median of $40.5 million in 2023 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2024 — Goodwill & Intangibles climbed 2.18% — and 2025, when it retreated 12.07%.
• Neurocrine Biosciences' Goodwill & Intangibles stood at $42.6 million in 2022, then dropped by 3.05% to $41.3 million in 2023, then advanced by 2.18% to $42.2 million in 2024, then dropped by 15.4% to $35.7 million in 2025.
• Business Quant data shows NBIX's Goodwill & Intangibles at $35.7 million in Q3 2025, $37.2 million in Q2 2025, and $36.4 million in Q1 2025.